6
Oct
2026

Miat SpA

Exhibitor at CPHI Milan 2026 stand 4D64, API
About Us

MIAT S.p.A. is an Italian Company certified ISO 9001 and 13485 for medical devices and having AIFA GMP approval for registering and handling APIs and pharmaceutical specialities. Miat is cooperating with Italian and International Institutes for R&D of specific projects allowing the possibility to offer new business opportunities.

Read more Show less
Categories
more categories Show less
  • Country/Region:
    Italy
  • On CPHI since:
    2018
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 4D64, API

Products Featured at CPHI Milan 2026

  • Diclofenac Epolamine Medicated Plaster

    Product Diclofenac Epolamine Medicated Plaster

    MIAT has developed and registered (Hybrid legal basis) in some European countries a medicated plaster based on Diclofenc Epolamine for the symptomatic local treatment of pain and inflammation of rheumatic or traumatic nature of joints, muscles, tendons and ligaments. The product is available only through i...
  • Sodium Hyaluronate (HA)

    Product Sodium Hyaluronate (HA)

    Miat offers Sodium Hyaluronate (i.e. HA) obtained by fermentation from Streptococcus equi subsp. Zooepidemicus, intended for Pharmaceutical  (available IV range 0.6-3.6 m3/kg) and Medical Device use (available IV range 0.1-3.6 m3/kg). The offered HA is supported by European documentation i.e. the ...
  • Eye Drops specialities

    Product Eye Drops specialities

    Unit Dose preservative free and multidose presentations
  • (S)-Glycidyl tetrahydro pyranyl ether

    Product (S)-Glycidyl tetrahydro pyranyl ether

     
    Application: Carvedilol

    From our Korean Partner RStech Corporation


  • (R)- Benzyl glycidyl ether

    Product (R)- Benzyl glycidyl ether



    Application: Intermediate

    From our Korean Partner RStech Corporation